Commit To Buy Intra-Cellular Therapies At $55, Earn 18.6% Annualized Using Options
Investors eyeing a purchase of Intra-Cellular Therapies Inc (Symbol: ITCI) shares, but tentative about paying the going market price of $62.88/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1670270816-0ad5575958954483983518d73656a96c.jpg "Should Military Members Open a Roth IRA?")